Zymeworks, Inc. (ZYME)
25.14
-0.70
(-2.71%)
USD |
NASDAQ |
Nov 18, 12:43
Zymeworks Gross Profit Margin (Quarterly) : 99.01% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.01% |
| June 30, 2026 | 57.43% |
| March 31, 2026 | -18.23% |
| December 31, 2025 | 32.76% |
| September 30, 2025 | 90.64% |
| June 30, 2025 | 93.40% |
| March 31, 2025 | 87.81% |
| December 31, 2024 | 88.11% |
| September 30, 2024 | 83.36% |
| June 30, 2024 | 86.86% |
| March 31, 2024 | 76.95% |
| December 31, 2023 | 80.22% |
| September 30, 2023 | 60.38% |
| June 30, 2023 | 35.49% |
| March 31, 2023 | 91.85% |
| December 31, 2022 | 99.43% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 75.33% |
| Faeth Therapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 89.75% |
| Alnylam Pharmaceuticals, Inc. | 75.19% |
| Anika Therapeutics, Inc. | 61.57% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 19.85% |
| Return on Assets | 7.75% |
| Return on Invested Capital | 9.37% |
| Profit Margin (Quarterly) | 67.73% |
| Operating Margin (Quarterly) | 69.25% |
| Return on Net Operating Assets | 17.43% |